Alerts will be sent to your verified email
Verify Email
COLINZ
|
Colinz Laboratories
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.71 % | 5.2 % | 10.99 % |
|
5yr average Equity Multiplier
|
1.29 | 1.99 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 1.33 | 0.25 |
|
5yr Avg Net Profit Margin
|
5.84 % | -0.06 % | 77.44 % |
|
Price to Book
|
1.11 | 0.84 | 1.5 |
|
P/E
|
22.26 | 79.96 | 36.09 |
|
5yr Avg Cash Conversion Cycle
|
-11.59 Days | 82.44 Days | 63.13 Days |
|
Inventory Days
|
56.66 Days | 64.96 Days | 54.75 Days |
|
Days Receivable
|
42.5 Days | 72.97 Days | 11.98 Days |
|
Days Payable
|
89.1 Days | 84.21 Days | 169.78 Days |
|
5yr Average Interest Coverage Ratio
|
11.55 | 2.35 | 820.35 |
|
5yr Avg ROCE
|
6.71 % | 5.35 % | 17.27 % |
|
5yr Avg Operating Profit Margin
|
7.54 % | 3.76 % | -130.11 % |
|
5 yr average Debt to Equity
|
0.07 | 0.49 | 0.0 |
|
5yr CAGR Net Profit
|
18.95 % | n/a | -26.08 % |
|
5yr Average Return on Assets
|
3.68 % | 0.6 % | 8.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.0 % | 51.49 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 1.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Colinz Laboratories
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|